Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Brainstorm Cell Therapeutics, Inc’s stock clocked out at $1.16, down -0.85% from its previous closing price of $1.17. In other words, the price has decreased by -$0.85 from its previous closing price. On the day, 98008.0 shares were traded. BCLI stock price reached its highest trading level at $1.19 during the session, while it also had its lowest trading level at $1.14.
Ratios:
To gain a deeper understanding of BCLI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.21 and its Current Ratio is at 0.21.
Maxim Group reiterated its Buy rating for the stock on December 19, 2016, while the target price for the stock was revised from $5 to $6.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 01 ’24 when Lebovits Chaim bought 1,836 shares for $3.43 per share. The transaction valued at 6,292 led to the insider holds 80,960 shares of the business.
Lebovits Chaim bought 22,000 shares of BCLI for $5,016 on Sep 30 ’24. The President & CEO now owns 1,186,865 shares after completing the transaction at $0.23 per share. On Jul 19 ’24, another insider, Dagher Ibrahim B., who serves as the Chief Medical Officer of the company, sold 63,000 shares for $0.35 each. As a result, the insider received 22,069 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCLI now has a Market Capitalization of 11413077 and an Enterprise Value of 9017541.
Stock Price History:
The Beta on a monthly basis for BCLI is 0.13, which has changed by -0.790991 over the last 52 weeks, in comparison to a change of 0.12792087 over the same period for the S&P500. Over the past 52 weeks, BCLI has reached a high of $6.45, while it has fallen to a 52-week low of $0.72. The 50-Day Moving Average of the stock is -0.03%, while the 200-Day Moving Average is calculated to be -31.22%.
Shares Statistics:
It appears that BCLI traded 1.37M shares on average per day over the past three months and 365940 shares per day over the past ten days. A total of 7.91M shares are outstanding, with a floating share count of 7.64M. Insiders hold about 22.32% of the company’s shares, while institutions hold 10.40% stake in the company. Shares short for BCLI as of 1749772800 were 463315 with a Short Ratio of 0.34, compared to 1747267200 on 209504. Therefore, it implies a Short% of Shares Outstanding of 463315 and a Short% of Float of 6.45.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
